Levofed DS 4 mg/4 ml (IV Infusion)
4 ml ampoule: ৳ 480.00
Medicine Details
Category | Details |
---|---|
Generic | Norepinephrine bitartrate |
Company | Beacon pharmaceuticals plc |
Also available as |
Indications
- Blood pressure control in acute hypotensive states
- Adjunct in treatment of cardiac arrest and profound hypotension
Pharmacology
- Direct-acting sympathomimetic
- Stimulates beta1- and alpha-adrenergic receptors
- Causes vasoconstriction
- Raises systolic and diastolic BP
Dosage & Administration
- Infusion into a large vein
- Dilution in 5% dextrose injection or 5% dextrose and sodium chloride injections
- Average Dosage calculation
- High Dosage titration
- Fluid Intake based on clinical fluid volume requirements
- Duration of Therapy considerations
- Adjunctive Treatment in Cardiac Arrest
Interaction
- Contradicted during cyclopropane and halothane anesthesia
- Caution in patients receiving MAOIs or antidepressants of specific types
Contraindications
- Hypotension from blood volume deficits
- Mesenteric or peripheral vascular thrombosis
- Anesthesia-related cardiac arrhythmias
- Not for continuous use without blood volume replacement
Side Effects
- Ischemic injury
- Bradycardia
- Arrhythmias
- Anxiety
- Headache
- Respiratory difficulty
- Extravasation necrosis at injection site
- Gangrene of extremities in rare cases
Pregnancy & Lactation
- Pregnancy Category C
- Caution in nursing women due to potential excretion in human milk
Precautions & Warnings
- Monitoring for hypertension
- Preferred site of infusion
- Extravasation precautions
- Antidote for extravasation ischemia
- Avoiding hypertension in elderly patients
- Carcinogenesis, Mutagenesis, Impairment of Fertility considerations
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- Caution in geriatric use
- No carcinoma, mutagenic, or fertility impairment studies
Overdose Effects
- Headache
- Severe hypertension
- Reflex bradycardia
- Marked increase in peripheral resistance
- Decreased cardiac output
Therapeutic Class
- Alpha and Beta-adrenergic agonist
Reconstitution
- Dilution with 5% glucose injection with or without sodium chloride
- Avoidance of dilution with sodium chloride injection alone
Storage Conditions
- Temperature not exceeding 30°C
- Dry place storage
- Protection from light